Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease?
ABSTRACT The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Nefrologia
2024-02-01
|
| Series: | Brazilian Journal of Nephrology |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024005005603&tlng=pt |
| _version_ | 1797302369160003584 |
|---|---|
| author | Mauricio de Carvalho Ita Pfeferman Heilberg |
| author_facet | Mauricio de Carvalho Ita Pfeferman Heilberg |
| author_sort | Mauricio de Carvalho |
| collection | DOAJ |
| description | ABSTRACT The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and potential effects of iSGLT2 in lithogenesis and try to answer the question: Should we also “gliflozin” our patients with kidney stone disease? |
| first_indexed | 2024-03-07T23:35:51Z |
| format | Article |
| id | doaj.art-d2171d5e2d7f44ca9b3cb62335b14a0a |
| institution | Directory Open Access Journal |
| issn | 2175-8239 |
| language | English |
| last_indexed | 2024-03-07T23:35:51Z |
| publishDate | 2024-02-01 |
| publisher | Sociedade Brasileira de Nefrologia |
| record_format | Article |
| series | Brazilian Journal of Nephrology |
| spelling | doaj.art-d2171d5e2d7f44ca9b3cb62335b14a0a2024-02-20T07:38:25ZengSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology2175-82392024-02-0110.1590/2175-8239-jbn-2023-0146enSodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease?Mauricio de Carvalhohttps://orcid.org/0000-0002-6314-7099Ita Pfeferman Heilberghttps://orcid.org/0000-0002-0885-5877ABSTRACT The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and potential effects of iSGLT2 in lithogenesis and try to answer the question: Should we also “gliflozin” our patients with kidney stone disease?http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024005005603&tlng=ptNephrolithiasisKidney CalculiSodium-Glucose Transporter 2 Inhibitors |
| spellingShingle | Mauricio de Carvalho Ita Pfeferman Heilberg Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? Brazilian Journal of Nephrology Nephrolithiasis Kidney Calculi Sodium-Glucose Transporter 2 Inhibitors |
| title | Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? |
| title_full | Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? |
| title_fullStr | Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? |
| title_full_unstemmed | Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? |
| title_short | Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease? |
| title_sort | sodium glucose cotranspor ter 2 sglt2 inhibitors in nephrolithiasis should we gliflozin patients with kidney stone disease |
| topic | Nephrolithiasis Kidney Calculi Sodium-Glucose Transporter 2 Inhibitors |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024005005603&tlng=pt |
| work_keys_str_mv | AT mauriciodecarvalho sodiumglucosecotransporter2sglt2inhibitorsinnephrolithiasisshouldwegliflozinpatientswithkidneystonedisease AT itapfefermanheilberg sodiumglucosecotransporter2sglt2inhibitorsinnephrolithiasisshouldwegliflozinpatientswithkidneystonedisease |